Bianual scholarships
Biannual grant for the study of colorectal cancer in terms of carcinogenesis mechanisms, prevention factors, disease progression, identification of new molecular lines, assessment of molecular variables to drug response, epidemiology, prognostic pathological factors, chemoprevention and new therapeutic approaches.
Grants granted:
2024/2025
Josep Bombardó Navinés. Established researchers
Dr. Jose Antonio Seoane
VHIO. Fundació Privada Institut de investigació Oncològica Vall d’Hebron
“Refined transcriptional subgroups of colorectal cancer patients harbouring the BRAF V600e mutation.”
Total amount: 60.000 €
Dionís Torres Segura. Emerging researchers
Dr. Núria Mulet Margalef
Institut de Investigació Germans Trias i Pujol (IGTP)
“Prospective Evaluation of multiple Biomarkers in Locally Advanced rectal Cancer: EMELARC Projec”.
Total amount: 60.000 €
2023/2024
Josep Bombardó Navinés. Established researchers
Dr. Carlos Sebastián Muñoz
Metabolic Dynamics in Cancer. Departamento de Biologia Celular, Fisiologia y Inmunologia. Universitat de Barcelona
“Definig metabòlic heterogeneity as a mechanism of immune evasion in colorectal càncer.”
Total amount: 60.000 €
Dionís Torres Segura. Emerging researchers
Dr. Maria Elena Élez Fernández
Colorectal Cancer Group. Fundació Privada Institut de Investigació Oncològica Vall d’Hebron (VHIO)
“Evaluation of tertiary lymphoid structures (TLS) as biomarker in metastàtic colorectal càncer treated with immune-checkpoint combinations”.
Total amount: 60.000 €
2022/2023
Josep Bombardó Navinés. Established researchers
Dr. Sonia Forcales Fernández
Chromatin Dynamics in Cancer and Cell fate. Facultat de Medicina. Universitat de Barcelona
“Identification and characterization of novel chromatin-targeting compounds that synergize with chemotherapy to overcome resistance in metastatic colorectal cancer.”
Total amount: 60.000 €
Dionís Torres Segura. Emerging researchers
Dr. Joffrey Pelletier
Laboratori Colorectal Cancer. Fundació Institut de Recerca Biomèdica (IRB Barcelona
“Targeting ribosomal biogenesis and cell autonomous inflammation as a novel differentiation therapy in colorectal càncer”.
Total amount: 60.000 €
2021/2022
Type A. Established researchers
Dr. Manel Esteller Badosa
Josep Carreras Leukaemia Research Institute. IJC. Badalona
“Deciphering the epigenomic signature induced by the carcinogenic pks+E.coli and its role in colorectal tumorigenesis.”
Total amount: 60.000 €
Type B. Emerging researchers
Drª Ceres Fernández Rozadilla
Fundación Instituto de Investigación Sanitaria de Santiago de Compostela. (IDIS). Fundacion Pública Galega de Medicina Xenómica. Santiago de Compostela.
“Omic-wide colorectal cancer risk deciphering the missing heritability -COALESCE.”
Total amount: 60.000 €
2020/2021
Type A. Established researchers
Dr. Eduard Batlle Gòmez
Institut de Recerca Biomèdica. IRB Barcelona. Barcelona
“Myeloid cell regulation of immune evasion in colorectal càncer.”
Total amount: 60.000 €
Type B. Emerging researchers
Dr. Alvaro Teijeira Sánchez
Fundación para la Investigación Médica Aplicada. FIMA. Pamplona (Navarra).
“Spatiotemporal dynamics of antitumor and pro-tumor immune responses in nascent and evolving colorectal cancer metastases to the liver.”
Total amount: 60.000 €
2019/2020
Type A. Established researchers
Dr. Antonio Postigo
Institut d’Investigacions Biomèdiques August Pi i Sunyer. IDIBAPS. Barcelona.
“Metabolic cooperation and competition between colorectal carcinomas (CRC) and their tumor microenvironment: Validation of ZEB factors as prognostic and predictive biomarkers and metabolic therapeutic targets in CRC.”
Total amount: 60.000 €
Type B. Emerging researchers
Dr. Ricky Shantilal Joshi
Josep Carreras Leukaemia Research Institute. IJC. Badalona.
“Studying the Clinical Impact of the Epitranscriptome for Colorectal Cancer Initiation, Progression and Treatment”
Total amount: 60.000 €
2018/2019
Type A. Established researchers
Drª Laura Valle Velasco
Institut Català d’Oncologia Institut d’Investigació Biomèdica de Bellvitge. ICO/IDIBELL. L’Hospitalet de Llobregat.
“Platform based on CRISPR/Cas-9-edited organoids for the functional evaluation of gene variants in colorectal cancer.”
Total amount: 60.000 €
Type B. Emerging researchers
Drª Ceres Fernàndez Rozadilla
Fundacion Pública Galega de Medicina Xenómica. Santiago de Compostela
“Novel liquid biopsy approaches to improve screening strategies for colorectal polyps and cancer.”
Total amount: 60.000 €
2017/2018
Type A. Established researchers
Dr. Manel Esteller Badosa
Institut d’Investigació Biomèdica de Bellvitge. IDIBELL. L’Hospitalet de Llobregat
“Bioinformatic prediction of chemosensitive profiles in colorectal cancer using Epigenomics.”
Total amount: 60.000 €
Type B. Emerging researchers
Dr. Rodrigo de Almeida Toledo
Institut d’Investigació Oncològica Vall d’Hebron. VHIO. Barcelona
“Evaluation of clonal evolution and changes in molecular dynamics evolution of colorectal cancers in patient’s blood.”
Total amount: 60.000 €
2016/2017
Type A. Established researchers
Dr. Eduard Batlle Gómez
Fundació Institut de Recerca Biomèdica. (IRB Barcelona)
“Evaluating immunotherapies in a preclinical model of metastatic colorectal cancer.”
Total amount: 60.000 €
Type B. Emerging researchers
Dr. Francesco Paolo Marchese
Center of Applied Medicine. (CIMA. Universidad de Navarra. Pamplona).
“Understanding the role of growth factors and nutrients in inflammatory bowell disease and colon cancer.”
Total amount: 60.000 €
2015/2016
Drª. Sonia-Vanina Forcales Fernández
Institut de Medicina Predictiva i Personalitzada del Càncer (IMPPC- Badalona)
“Identification of chromatin biomarkers for predicting and sensitizing response to current treatments in colorectal cancer.”
Total amount: 60.000 €
Dr. Nabil Djouder
Centro Nacional de Investigaciones Oncológicas (CNIO- Madrid)
“Understanding the role of growth factors and nutrients in inflammatory bowell disease and colon cancer.”
Total amount: 60.000 €
2014/2015
Drª. Raquel Batlle
Institute for Research in Biomedicine (IRB Barcelona)
“Contribution of p38 MAPK signaling to colitis-associated colorectal tumorigenesis.”
Total amount: 60.000 €
Dr. Holger Heyn
Institut d’Investigació Biomèdica de Bellvitge IDIBELL
“Systems Colorectal Cancer Genomics”
Total amount: 60.000 €
2013/2014
Drª. Enza Lonardo
Institute for Research in Biomedicine (IRB Barcelona)
“Molecular characterization and targeted elimination of the TGF-beta-driven metastasis niche by colorectal cancer vstem cells (CRC-SCs)”
“Molecular characterization and targeted elimination of the TGF-beta-driven metastasis niche by colorectal cancer vstem cells (CRC-SCs).”
Total amount: 60.000 €
Drª. Mireia Jordà Ramos
Institut de Medicina Predictiva i Personalitzada del Càncer. IMPPC
“Disruption of repeat DNA epigenetic signatures as an oncogenic mechanism: uncovering a new source of biomarkers in colorectal cancer”
“Disruption of repeat DNA epigenetic signatures as an oncogenic mechanism: uncovering a new source of biomarkers in colorectal cancer.”
Total amount: 60.000 €
2012/2013
Drª. Anna Martínez Cardús
Grup d’Epigenètica del càncer. IDIBELL
“Study of epigenetic modifications at the onset of liver metastases. Potential applicability as predictive factors of relapse”
Total amount: 60.000 €
Drª. Jelena Urosevic
Institute for Research in Biomedicine (IRB Barcelona)
“Identification and characterization of genes associated with metastasis of colorectal cancer”
Total amount: 60.000 €
2011/2012
Drª. Anna Merlos Suàrez
Institute for Research in Biomedicine (IRB Barcelona)
“Mother cells in colorectal cancer: Characterization and therapeutic approach”
Total amount: 60.000 €
Drª. Marta Crous Bou
Biomarker and susceptibility Unit. IDIBELL
“Validation of new biomarkers for preventive diagnosis of colorectal cancer”
Total amount: 60.000 €
2010/2011
Drª. Clara Ruiz Ponte
Fundación Pública Galega de Medicina Xenómica. Santiago de Compostela
“Nine genetic variants of susceptibility to colorectal cancer: pangenomic association study, replication of results and correlation with clinical variables”
Total amount: 60.000 €
Drª. Meritxell Gironella Cos
Grup CIBERehd. (Hospital Clínic. Barcelona)
“Analysis of expression profiles of microRNAs in the non-invasive diagnosis of colonic neoplastic lesions”
Total amount: 60.000 €
2009/2010
Drª. María Verónica Dávalos Vega
Grup d’Epigenètica del càncer. IDIBELL, Hospital Duran i Reynals. (L’Hospitalet de Llobregat)
“Study on the relationship between epigenome and microRNAs in colorectal cancer”
Total amount: 60.000 €.
Dr. Antonio Postigo
Grup IDIBAPS (Hospital Clínic. Barcelona)
“Transcriptional regulation of E-cadherin and invasive and metastatic capacity of tumours of the colon”
Total amount: 60.000 €
2008/2009
Dr. Stephan Tenbaum
Stem Cell and Cancer Research Group. Institut d’Oncologia Vall d’Hebron (VHIO, Barcelona)
“Tumor stem cells in cancer of the colon.”
Total amount: 60.000 €
Drª. Eva Martínez Balibrea
Laboratory Research Group of the Research Institute in Health Sciences. Hospital Universitari Germans Trias i Pujol (ICO-Badalona)
“Study of the role of pyruvate kinase m2 isoform (PK-M2) in the response and resistence to exaliplatine in cells lines and patients with advanced colorectal cancer”
Total amount: 60.000 €
2007/2008
Dr. Sergi Castellví Bel
Gastrointestinal Oncology Group (Hospital Clínic. Barcelona)
“Susceptibility polymorphisms to colorectal cancer: Characterisation of common genetic and low penetrance in chromosomal region components 3q21-q35”
Total amount: 60.000 €.
2006/2007
Team led by Professor Dr Josep Mª Ramon
Hospital de Bellvitge (L’Hospitalet de Llobregat)
“D Vitamin and colorectal cancer.”
Total amount: 36.000 €
2005/2006
Team led by Professor Dr Mariano Monzó
Hospital Clínic (Barcelona)
“Study of marker Stem cells in colorectal cancer”
Total amount: 36.000 €